Artivion, Inc. announced financial results for the fourth quarter and full year ended December 31, 2023. “2023 was a standout year for Artivion as we exceeded...
PacBio announced financial results for the quarter and fiscal year ended December 31, 2023. Fourth quarter results Revenue of $58.4 million, a 113% increase compared with $27.4...
AngioDynamics, Inc. announced that it has completed the sale of its PICC and Midline product portfolios to Spectrum Vascular, an innovative medical device company focused on...
T2 Biosystems, Inc. announced the entrance into a definitive agreement to convert $15 million of its term loan with entities affiliated with CRG Servicing LLC into...
Vivos Therapeutics, Inc. announced that it has entered into a definitive agreement for the immediate exercise of an outstanding common stock purchase warrant held by an...
Bio-Rad Laboratories, Inc. announced financial results for the fourth quarter and full year ended December 31, 2023. Fourth-quarter 2023 total net sales were $681.2 million, a...
GE HealthCare Technologies Inc announced the launch of a secondary underwritten public offering of 13,000,000 shares of its common stock. GE HealthCare is not selling any...
Labcorp announced results for the fourth quarter and year ending Dec. 31, 2023, and full year 2024 guidance. “We made significant progress on our strategy in...
Vessi Medical Ltd. announced that it has closed a Series A financing round of $16.5 million for its cryotherapy technology to treat Non Muscle Invasive Bladder...
Impulse Dynamics plc announced that it raised $136 million in financing to accelerate investment in global commercialization, technology, product innovation, and further development of clinical evidence....
Cotiviti announced that the Company has entered into a definitive agreement to recapitalize the business with affiliates of its long-standing partner Veritas Capital, and investment funds...
NeuroOne Medical Technologies Corporation announced its operating results for the first quarter fiscal year 2024 ended December 31, 2023. Dave Rosa, CEO of NeuroOne, commented, “We...
Microbix Biosystems Inc. reports results for its first quarter of fiscal 2024 ended December 31, 2023, with record quarterly revenues and a record quarterly profit, reflective...
Eris Lifesciences Ltd. announced the expansion of its Sterile Injectables footprint through the acquisition of 51% equity stake in Swiss Parenterals Ltd. for a consideration of...
Know Labs, Inc. reported financial results for the first quarter ended December 31, 2023. Financial highlights: In Q1 FY 2024, Know Labs reported a net loss...
Copyright © 2024 Medical Buyer